Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada.
Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Alberta T6G 2 × 4, Canada.
Bioconjug Chem. 2024 Feb 21;35(2):232-244. doi: 10.1021/acs.bioconjchem.3c00522. Epub 2024 Jan 12.
Transition-metal-mediated bioconjugation chemistry has been used extensively to design and synthesize molecular probes to visualize, characterize, and quantify biological processes within intact living organisms at the cellular and subcellular levels. We demonstrate the development and validation of chemoselective [F]fluoro-arylation chemistry of cysteine residues using Pd-mediated -arylation chemistry with 4-[F]fluoroiodobenzene ([F]FIB) as an aryl electrophile. The novel bioconjugation technique proceeded in excellent radiochemical yields of 73-96% within 15 min under ambient and aqueous reaction mixture conditions, representing a versatile novel tool for decorating peptides and peptidomimetics with short-lived positron emitter F. The chemoselective -arylation of several peptides and peptidomimetics containing multiple reactive functional groups confirmed the versatility and functional group compatibility. The synthesis and radiolabeling of a novel prostate-specific membrane antigen (PSMA) binding radioligand was accomplished using the novel labeling protocol. The validation of radioligand in a preclinical prostate cancer model with PET resulted in favorable accumulation and retention in PSMA-expressing LNCaP tumors. At the same time, a significantly lower salivary gland uptake was observed compared to clinical PSMA radioligand [F]PSMA-1007. This finding coincides with ongoing discussions about the molecular basis of the off-target accumulation of PSMA radioligands currently used for clinical imaging and therapy of prostate cancer.
过渡金属介导的生物共轭化学已被广泛用于设计和合成分子探针,以在完整的活生物体中可视化、表征和量化细胞和亚细胞水平的生物过程。我们展示了使用 Pd 介导的芳基化化学,通过 4-[F]氟碘苯([F]FIB)作为芳基亲电试剂,对半胱氨酸残基进行选择性[F]氟芳基化化学的开发和验证。在环境和水相反应混合物条件下,新的生物偶联技术在 15 分钟内以 73-96%的优异放射化学产率进行,代表了一种用于用短寿命正电子发射体 F 修饰肽和拟肽的多功能新型工具。几种含有多个反应性官能团的肽和拟肽的选择性[F]芳基化证实了其多功能性和官能团兼容性。使用新型标记方案完成了新型前列腺特异性膜抗原 (PSMA) 结合放射性配体的合成和放射性标记。新型放射性配体在具有 PET 的临床前前列腺癌模型中的验证导致在表达 PSMA 的 LNCaP 肿瘤中有利的积累和保留。同时,与目前用于前列腺癌临床成像和治疗的临床 PSMA 放射性配体[F]PSMA-1007 相比,观察到唾液腺摄取显著降低。这一发现与目前正在进行的关于 PSMA 放射性配体非靶标积累的分子基础的讨论相吻合,这些配体目前用于临床成像和治疗前列腺癌。